Mokari Atabak's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed Aug 3, 2026
- Accession no.
- 0001193125-26-330668
- Filed
- Aug 3, 2026, 4:30 PM ET
- Trade date
- Jul 30, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 14 non-derivative transactions and 1 derivative transaction. Open-market sales total $9.18M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mokari AtabakCIK 0001678419 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Common Stock | MOption exerciseAcquired | +80,000 | $23.06 | +$1,844,800 | 96,130 | Direct | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −4,200 | $105.54F3 | −$443,247.84 | 91,930 | Direct | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −8,956 | $106.96F4 | −$957,891.67 | 82,974 | Direct | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −400 | $108.46 | −$43,384 | 82,574 | Direct | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −2,202 | $110.03F5 | −$242,282.32 | 80,372 | Direct | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −600 | $110.95 | −$66,570 | 79,772 | Direct | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −4,700 | $113.18F6 | −$531,940.83 | 75,072 | Direct | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −15,477 | $114.96F7 | −$1,779,237.47 | 59,595 | Direct | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −14,222 | $115.87F8 | −$1,647,859.05 | 45,373 | Direct | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −7,089 | $116.96F9 | −$829,101.79 | 38,284 | Direct | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −8,267 | $117.93F10 | −$974,951.28 | 30,017 | Direct | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −4,783 | $118.73F11 | −$567,907.59 | 25,234 | Direct | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −8,103 | $119.95F12 | −$971,939.45 | 17,131 | Direct | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −1,001 | $120.67F13 | −$120,795.57 | 16,130 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Common Stock | MOption exerciseDisposed | −80,000 | $0.00 | $0 | 95,833 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $105.305 to $106.2 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $106.75 to $107.195 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $109.71 to $110.42 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $112.96 to $113.89 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F7
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.305 to $115.30 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F8
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.35 to $116.27 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F9
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.35 to $117.3 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F10
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $117.41 to $118.39 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F11
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $118.42 to $119.21 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F12
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $119.42 to $120.41 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F13
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $120.49 to $120.84 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
Remarks
The power of attorney under which this form was signed is on file with the Commission.